5-Fluorouracil-based chemotherapy for colorectal cancer and MTHFR/MTRR genotypes

被引：89

作者：

Pardini, Barbara ^{[1
]}

Kumar, Rajiv ^{[2
]}

Naccarati, Alessio ^{[1
]}

Novotny, Jan ^{[3
]}

Prasad, Rashmi B. ^{[2
]}

Forsti, Asta ^{[2
,4
]}

Hemminki, Kari ^{[2
,4
]}

Vodicka, Pavel ^{[1
]}

Bermejo, Justo Lorenzo ^{[2
,5
]}

机构：

[1] Acad Sci Czech Republic, Inst Expt Med, Prague 14220 4, Czech Republic

[2] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany

[3] Charles Univ Prague, Fac Med 1, Prague, Czech Republic

[4] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden

[5] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 72卷 / 01期

关键词：

GENE POLYMORPHISMS; DNA-DAMAGE; FLUOROURACIL; CYTOTOXICITY; RESISTANCE; MECHANISMS; CELLS;

D O I：

10.1111/j.1365-2125.2010.03892.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：162 / 163

页数：2

共 50 条

[21] FANCJ Expression Predicts the Response to 5-Fluorouracil-Based Chemotherapy in MLH1-Proficient Colorectal Cancer
Ryota Nakanishi
Hiroyuki Kitao
Yoshihiko Fujinaka
Nami Yamashita
Makoto Iimori
Eriko Tokunaga
Natsumi Yamashita
Masaru Morita
Yoshihiro Kakeji
Yoshihiko Maehara
Annals of Surgical Oncology, 2012, 19 : 3627 - 3635
[22] Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy:: Efficacy and prognostic factors
Karaoglu, A
Yalcin, S
Tekuzman, G
Kars, A
Çelik, I
Güler, N
Özisik, Y
Türker, A
Barista, I
Güllü, I
TUMORI, 2003, 89 (02) : 141 - 145
[23] Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy
Lecomte, T
Ferraz, JM
Zinzindohoué, F
Loriot, MA
Tregouet, DA
Landi, B
Berger, A
Cugnenc, PH
Jian, R
Beaune, P
Laurent-Puig, P
CLINICAL CANCER RESEARCH, 2004, 10 (17) : 5880 - 5888
[24] FANCJ Expression Predicts the Response to 5-Fluorouracil-Based Chemotherapy in MLH1-Proficient Colorectal Cancer
Nakanishi, Ryota
Kitao, Hiroyuki
Fujinaka, Yoshihiko
Yamashita, Nami
Iimori, Makoto
Tokunaga, Eriko
Yamashita, Natsumi
Morita, Masaru
Kakeji, Yoshihiro
Maehara, Yoshihiko
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (11) : 3627 - 3635
[25] Irinotecan (CPT-11) in patients with advanced colorectal cancer previously treated with 5-fluorouracil-based chemotherapy
Aravantinos, G
Skarlos, DV
Kosmidis, P
Georgoulias, V
Sgouros, I
Bafaloukos, D
Androulakis, N
Florou, S
Fountzilas, G
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1999, 32 (03) : 209 - 219
[26] GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
Zaozao Wang
Beihai Jiang
Lei Chen
Jiabo Di
Ming Cui
Maoxing Liu
Yiyuan Ma
Hong Yang
Jiadi Xing
Chenghai Zhang
Zhendan Yao
Nan Zhang
Bin Dong
Jiafu Ji
Xiangqian Su
Journal of Translational Medicine, 12
[27] An SNP Marker Predicts Colorectal Cancer Outcomes with 5-Fluorouracil-Based Adjuvant Chemotherapy Post-Resection
Chien, Hao
Chu, Yu-De
Hsu, Yi-Ping
Yeh, Chau-Ting
Lai, Ming-Wei
Chang, Ming-Ling
Lim, Siew-Na
Chen, Chun-Wei
Lin, Wey-Ran
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
[28] Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer:: a pooled analysis of clinical trials
Folprecht, G
Cunningham, D
Ross, P
Glimelius, B
Di Costanzo, F
Wils, J
Scheithauer, W
Rougier, P
Aranda, E
Hecker, H
Köhne, CH
ANNALS OF ONCOLOGY, 2004, 15 (09) : 1330 - 1338
[29] Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy
Hakamada, Y
Tsuchida, A
Arima, M
Kubouchi, T
Tokita, H
Ota, D
Kaise, H
Aoki, T
Kusama, M
Aoki, T
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 16 (02) : 309 - 314
[30] Prediction of pathological response of preorerative 5-fluorouracil-based chemotherapy for oral cancer
Nakazawa, M.
Takabatake, R.
Meshii, T.
Iwai, S.
Kato, I.
Amino, K.
Takeuchi, N.
EJC SUPPLEMENTS, 2009, 7 (02): : 478 - 478

← 1 2 3 4 5 →